IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.552
AS - Asia 4.098
EU - Europa 3.761
SA - Sud America 699
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 12
Totale 15.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.445
SG - Singapore 1.861
CN - Cina 1.189
IE - Irlanda 770
UA - Ucraina 619
BR - Brasile 592
SE - Svezia 533
IT - Italia 458
TR - Turchia 421
GB - Regno Unito 339
DE - Germania 284
VN - Vietnam 257
FR - Francia 198
FI - Finlandia 178
RU - Federazione Russa 164
IN - India 99
HK - Hong Kong 67
CA - Canada 58
AR - Argentina 48
AT - Austria 45
ES - Italia 36
MX - Messico 33
PL - Polonia 33
NL - Olanda 31
BD - Bangladesh 27
JP - Giappone 26
BE - Belgio 25
TW - Taiwan 23
ZA - Sudafrica 23
ID - Indonesia 21
EC - Ecuador 20
KR - Corea 14
CZ - Repubblica Ceca 13
CO - Colombia 12
EU - Europa 12
IQ - Iraq 12
PK - Pakistan 12
AU - Australia 11
EG - Egitto 9
MA - Marocco 9
IL - Israele 8
IR - Iran 7
UZ - Uzbekistan 7
KE - Kenya 6
LT - Lituania 6
PY - Paraguay 6
RO - Romania 6
TH - Thailandia 6
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JO - Giordania 4
PE - Perù 4
VE - Venezuela 4
CL - Cile 3
DK - Danimarca 3
EE - Estonia 3
HR - Croazia 3
JM - Giamaica 3
MY - Malesia 3
NO - Norvegia 3
QA - Qatar 3
SR - Suriname 3
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
OM - Oman 2
PH - Filippine 2
TL - Timor Orientale 2
AL - Albania 1
AM - Armenia 1
CH - Svizzera 1
DM - Dominica 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
Totale 15.198
Salva come PNG Salva come JPEG
Città #
Singapore 1.286
Chandler 1.002
Jacksonville 864
Dublin 759
Princeton 393
Ashburn 373
Dallas 371
Beijing 299
Izmir 271
Nanjing 215
Altamura 184
Los Angeles 181
Southend 177
Wilmington 169
Santa Clara 165
Cambridge 137
Dearborn 132
The Dalles 118
Ho Chi Minh City 97
Boardman 90
Ann Arbor 83
Buffalo 79
Tongling 76
Houston 73
Nanchang 71
Woodbridge 68
São Paulo 67
New York 66
Hong Kong 65
Helsinki 62
Chieti 61
Redondo Beach 61
Munich 50
Hebei 46
Kunming 46
Seattle 38
Hanoi 37
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Dong Ket 31
Warsaw 30
Vienna 29
Nuremberg 28
Pescara 26
Changsha 25
Hefei 24
Brussels 23
Tokyo 23
Montreal 22
Norwalk 22
Poplar 22
Chicago 21
London 21
Brooklyn 19
Denver 19
Atlanta 17
Guangzhou 17
Hangzhou 17
San Francisco 17
Phoenix 16
Boston 15
Johannesburg 15
Orem 15
Stockholm 15
Chennai 14
Fairfield 14
Pune 14
Rio de Janeiro 14
Falls Church 13
Haiphong 13
Leawood 13
Amsterdam 12
Taipei 12
Turku 12
Brasília 11
Grevenbroich 11
Guayaquil 11
Olomouc 11
Ankara 10
Belo Horizonte 10
Manchester 10
San Mateo 10
Shanghai 10
Toronto 10
Buenos Aires 9
Edinburgh 9
Jinan 9
Moscow 9
Mumbai 9
Porto Alegre 9
Seoul 9
Sorocaba 9
Sydney 9
Changchun 8
Madrid 8
Rome 8
Romola 8
Salvador 8
Totale 9.359
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 218
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 149
Supportive management strategies for disseminated intravascular coagulation: An international consensus 146
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 141
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 140
Circulating leptin is associated with oxidized LDL in postmenopausal women. 119
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 118
Treatment of Lower Extremity Superficial Thrombophlebitis 118
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 110
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 110
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 108
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 108
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 108
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 108
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 108
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 107
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 105
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 103
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 103
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 103
Non-O blood group and outcomes of in vitro fertilization 100
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 100
Rivaroxaban for cancer-associated cardiac thrombosis 98
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 98
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 97
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 97
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 97
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 96
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 95
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 95
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 95
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 95
The hematocrit and platelet target in polycytemia vera 94
Antithrombotic therapy and cancer 93
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 93
Effects of body composition on the procoagulant imbalance in obese patients 93
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 92
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 91
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 91
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 90
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 90
Improving the diagnostic management of upper extremity deep vein thrombosis 89
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 89
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 89
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 89
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 89
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 88
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 88
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 87
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 87
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 86
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis 86
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 85
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 85
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 83
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 83
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 83
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 83
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 82
Obesity, Poor Muscle Strength and the Risk of Venous Thromboembolism in Older Persons: the InCHIANTI Study 82
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 82
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 82
Edoxaban for the treatment of cancer-associated venous thromboembolism 82
D-Dimer test in cancer patients with suspected acute pulmonary embolism 82
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 82
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 81
Decision analysis for cancer screening in idiopathic venous thromboembolism 81
Cannabinoids for medical use: A systematic review and meta-analysis 81
Deep vein thrombosis and pulmonary embolism 81
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 81
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 81
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 81
Treatment for superficial infusion thrombophlebitis of the upper extremity. 80
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 80
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 80
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 80
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 80
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants 79
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 79
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study 79
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 79
The SISET incorrectly cited the JAAM DIC scoring system 78
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 78
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 78
Cancer-associated unsuspected pulmonary embolism 78
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 78
Low molecular-weight heparins improve the survival of cancer patients? 77
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 77
Safety and feasibility of diagnostic algorithm combining clinical probability, D-dimer and ultrasonography in suspected upper extremity deep vein thrombosis: a prospective management study. 77
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 77
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 77
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients 77
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 77
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis 76
Cell-derived microvesicles and cancer 76
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 76
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis 76
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 76
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment 76
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life 76
Totale 9.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 228 10 9 12 68 50 79
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.995 200 619 402 63 52 98 76 250 345 130 353 407
2025/20263.194 506 273 772 855 718 70 0 0 0 0 0 0
Totale 15.928